Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains.

  • Authors : Peng K; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.; Wallace SD

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/chemistry ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/metabolism

  • Source: ACS chemical biology [ACS Chem Biol] 2024 May 17; Vol. 19 (5), pp. 1093-1105. Date of Electronic Publication: 2024 Apr 22.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

NAD+-consuming enzymes in immune defense against viral infection.

  • Authors : Shang J; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, U.S.A.; Smith MR

Subjects: Immunity, Innate*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; NAD/NAD/NAD/*metabolism

  • Source: The Biochemical journal [Biochem J] 2021 Dec 10; Vol. 478 (23), pp. 4071-4092.Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited

Record details

×
Academic Journal

Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy.

  • Authors : Shang J; Centre of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Liu H

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis B virus/Hepatitis B virus/Hepatitis B virus/*physiology ; Hepatitis B, Chronic/Hepatitis B, Chronic/Hepatitis B, Chronic/*drug therapy

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Apr;Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b.

  • Authors : Ji F; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Li J

Subjects: Genetic Association Studies* ; Genotype*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Mar; Vol. 36 (3), pp. 767-774. Date of Electronic Publication: 2020 Aug 05.Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks.

  • Authors : Wang X; Department of Hepatology, the First Hospital of Jilin University, Changchun, China.; Wang Z

Subjects: Seroconversion*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Guanine/Guanine/Guanine/*analogs & derivatives

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Oct;Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study.

  • Authors : Zhang M; Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.; Li G

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis B Surface Antigens/Hepatitis B Surface Antigens/Hepatitis B Surface Antigens/*blood ; Hepatitis B e Antigens/Hepatitis B e Antigens/Hepatitis B e Antigens/*blood

  • Source: Hepatology international [Hepatol Int] 2020 Mar; Vol. 14 (2), pp. 212-224. Date of Electronic Publication: 2020 Feb 25.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.

  • Authors : Yang HI; Genomics Research Center, Academia Sinica, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

Subjects: Research Design*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*adverse effects ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: The Journal of infectious diseases [J Infect Dis] 2020 Jan 14; Vol. 221 (3), pp. 389-399.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48.

  • Authors : Liang RY; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Peking.; Xu JH

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis B, Chronic/Hepatitis B, Chronic/Hepatitis B, Chronic/*drug therapy ; Tenofovir/Tenofovir/Tenofovir/*therapeutic use

  • Source: Medicine [Medicine (Baltimore)] 2019 Aug; Vol. 98 (33), pp. e16778.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].

  • Authors : Miao L; Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China; Department of Hepatology, the Third Hospital of Qinhuangdao, Qinhuangdao 066000, China.

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Drugs, Chinese Herbal/Drugs, Chinese Herbal/Drugs, Chinese Herbal/*therapeutic use ; Guanine/Guanine/Guanine/*analogs & derivatives

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2019 Jul 20; Vol. 27 (7), pp. 521-526.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
Academic Journal

[A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection].

  • Authors : Gao YH; Department of Hepatology, Peking University People's Hospital, Beijing 100044, China (now in Peking University International Hospital).; Li GM

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepacivirus/Hepacivirus/Hepacivirus/*classification ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2019 May 20; Vol. 27 (5), pp. 352-357.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
  • 1-10 of  27 results for ""Shang J""